Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1987 1
1988 1
1989 1
1995 1
1996 1
1998 2
2000 1
2004 1
2008 2
2009 1
2010 5
2011 1
2012 2
2013 2
2014 3
2015 4
2016 2
2017 1
2018 2
2019 2
2020 3
2021 6
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the contribution of mitochondrial dynamics to multiple acyl-CoA dehydrogenase deficiency-related phenotype.
Brandão SR, Ferreira R, Rocha H. Brandão SR, et al. Arch Physiol Biochem. 2021 Jun;127(3):210-216. doi: 10.1080/13813455.2019.1628065. Epub 2019 Jun 19. Arch Physiol Biochem. 2021. PMID: 31215835 Review.
Emphasis is given to the signaling pathways involving MnSOD, sirtuins and PGC-1alpha, which seem to contribute to FAOD phenotype, namely to multiple acyl-CoA dehydrogenase deficiency (MADD). The association between phenotype and genotype is not …
Emphasis is given to the signaling pathways involving MnSOD, sirtuins and PGC-1alpha, which seem to contribute to FAOD phenotype, namely to …
Metabolic myopathies.
Tein I. Tein I. Semin Pediatr Neurol. 1996 Jun;3(2):59-98. doi: 10.1016/s1071-9091(96)80038-6. Semin Pediatr Neurol. 1996. PMID: 8795843 Review.
Disorders of glycogen, lipid or mitochondrial metabolism may cause two main clinical syndromes, namely (1) progressive weakness (eg, acid maltase, debrancher enzyme, and brancher enzyme deficiencies among the glycogenoses; long- and very-long-chain acyl-CoA dehyd …
Disorders of glycogen, lipid or mitochondrial metabolism may cause two main clinical syndromes, namely (1) progressive weakness (eg, acid ma …
Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.
Yamada K, Taketani T. Yamada K, et al. J Hum Genet. 2019 Feb;64(2):73-85. doi: 10.1038/s10038-018-0527-7. Epub 2018 Nov 6. J Hum Genet. 2019. PMID: 30401918 Review.
Mitochondrial fatty acid oxidation disorders (FAODs) are caused by defects in beta-oxidation enzymes, including very long-chain acyl-CoA dehydrogenase (VLCAD), trifunctional protein (TFP), carnitine palmitoyltransferase-2 (CPT2), carnitine-acylcarnitine trans …
Mitochondrial fatty acid oxidation disorders (FAODs) are caused by defects in beta-oxidation enzymes, including very long-chain acyl- …
Lipid storage myopathy.
Liang WC, Nishino I. Liang WC, et al. Curr Neurol Neurosci Rep. 2011 Feb;11(1):97-103. doi: 10.1007/s11910-010-0154-y. Curr Neurol Neurosci Rep. 2011. PMID: 21046290 Review.
Although extensive molecular studies have been performed, there are only four types of genetically diagnosable LSMs: primary carnitine deficiency (PCD), multiple acyl-coenzyme A dehydrogenase deficiency (MADD), neutral lipid storage disea …
Although extensive molecular studies have been performed, there are only four types of genetically diagnosable LSMs: primary carnitine de …
Spectrum of metabolic myopathies.
Angelini C. Angelini C. Biochim Biophys Acta. 2015 Apr;1852(4):615-21. doi: 10.1016/j.bbadis.2014.06.031. Epub 2014 Jul 2. Biochim Biophys Acta. 2015. PMID: 24997454 Free article. Review.
This review is focused on recent advances about GSDII and its treatment, and the most recent notions about the management and treatment of other metabolic myopathies will be briefly reviewed, including glycogenosis type V (McArdle disease), glycogenosis type III (debrancher enzym …
This review is focused on recent advances about GSDII and its treatment, and the most recent notions about the management and treatment of o …
Functions of Intracellular Retinoid Binding-Proteins.
Napoli JL. Napoli JL. Subcell Biochem. 2016;81:21-76. doi: 10.1007/978-94-024-0945-1_2. Subcell Biochem. 2016. PMID: 27830500 Free PMC article. Review.
Multiple binding and transport proteins facilitate many aspects of retinoid biology through effects on retinoid transport, cellular uptake, metabolism, and nuclear delivery. ...
Multiple binding and transport proteins facilitate many aspects of retinoid biology through effects on retinoid transport, cellular u …
Riboflavin in Neurological Diseases: A Narrative Review.
Plantone D, Pardini M, Rinaldi G. Plantone D, et al. Clin Drug Investig. 2021 Jun;41(6):513-527. doi: 10.1007/s40261-021-01038-1. Epub 2021 Apr 22. Clin Drug Investig. 2021. PMID: 33886098 Review.
Brown-Vialetto-Van Laere syndrome and Fazio-Londe diseases are now renamed as "riboflavin transporter deficiency" because these are autosomal recessive diseases caused by mutations of SLC52A2 and SLC52A3 genes that encode riboflavin transporters. ...Remarkably, some mitoch …
Brown-Vialetto-Van Laere syndrome and Fazio-Londe diseases are now renamed as "riboflavin transporter deficiency" because these are a …
ETF dehydrogenase advances in molecular genetics and impact on treatment.
Missaglia S, Tavian D, Angelini C. Missaglia S, et al. Crit Rev Biochem Mol Biol. 2021 Aug;56(4):360-372. doi: 10.1080/10409238.2021.1908952. Epub 2021 Apr 7. Crit Rev Biochem Mol Biol. 2021. PMID: 33823724 Review.
ETF-QO mutations are often associated with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (RR-MADD, OMIM#231680), a multisystem genetic disease characterized by various clinical manifestations with different degrees of severity …
ETF-QO mutations are often associated with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency …
Riboflavin transport and metabolism in humans.
Barile M, Giancaspero TA, Leone P, Galluccio M, Indiveri C. Barile M, et al. J Inherit Metab Dis. 2016 Jul;39(4):545-57. doi: 10.1007/s10545-016-9950-0. Epub 2016 Jun 6. J Inherit Metab Dis. 2016. PMID: 27271694 Review.
Alteration of this network may be causative of severe metabolic disorders such as multiple acyl-CoA dehydrogenase deficiency (MADD) or Brown-Vialetto-van Laere syndrome. ...
Alteration of this network may be causative of severe metabolic disorders such as multiple acyl-CoA dehydrogenase …
Neonatal-onset multiple acyl-CoA dehydrogenase deficiency (MADD) in the ETFDH gene: A case report and a literature review.
Ding M, Liu R, Qiubo L, Zhang Y, Kong Q. Ding M, et al. Medicine (Baltimore). 2020 Sep 11;99(37):e21944. doi: 10.1097/MD.0000000000021944. Medicine (Baltimore). 2020. PMID: 32925727 Free PMC article. Review.
RATIONALE: Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare inborn error of metabolism affecting fatty acid, amino acid, and choline metabolism. ...Serum tandem mass spectrometry analysis indicated elevated levels of various acyl …
RATIONALE: Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare inborn error of metabolism affecti …
43 results